Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors

This study has been completed.

First Received: July 7, 2008 Last Updated: March 10, 2009 History of Changes

Sponsored by:	Weill Medical College of Cornell University
Information provided by:	Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:	NCT00713882

Purpose

The aims and objectives of this research are to identify chronic health conditions, psychological disease, quality of life issues, and patient preferences for survivorship care in patients who have survived aggressive lymphoma.

Subjects will be asked to participate in an oral interview with the primary investigator, either in-person or over the telephone. It is estimated that the survey will take about an hour.

Condition
Lymphoma, Non-Hodgkins Hodgkins Disease

MedlinePlus related topics: Hodgkin's Disease Lymphoma

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Cross-Sectional
Official Title:	Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors

Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:

Quality of life [ Time Frame: cross-sectional (time of interview) ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	130
Study Start Date:	April 2008
Study Completion Date:	November 2008
Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)

Groups/Cohorts
Observational

Show Detailed Description

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patients will be identified via physician referral at Weill Cornell Medical College, Hematology-Oncology outpatient clinic, or self-referral.

Criteria

Inclusion Criteria:

adults who have been treated for either aggressive lymphoma (Hodgkins lymphoma, diffuse large B-cell lymphoma, follicular grade III NHL, or others)
are greater than 2 years from the time of last treatment
no known active cancer

Exclusion Criteria:

unable to participate in an interview in English
indolent lymphoma (i.e. non-curable, including follicular grades 1-2 NHL)

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00713882

Locations

United States, New York
Weill Cornell Medical College
New York, New York, United States, 10065

Sponsors and Collaborators

Weill Medical College of Cornell University

Investigators

Principal Investigator:

Carrie A Thompson, M.D.

Weill Cornell Medical College

More Information

No publications provided

Responsible Party:	Weill Cornell Medical College ( Carrie A. Thompson, M.D. )
Study ID Numbers:	0802009649
Study First Received:	July 7, 2008
Last Updated:	March 10, 2009
ClinicalTrials.gov Identifier:	NCT00713882 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Weill Medical College of Cornell University:

Survivors
Quality of Life

Study placed in the following topic categories:

Lymphatic Diseases
Immunoproliferative Disorders
Hodgkin Lymphoma, Adult
Hodgkin's Disease
Quality of Life

Lymphoproliferative Disorders
Lymphoma, Non-Hodgkin
Hodgkin Disease
Lymphoma

Additional relevant MeSH terms:

Lymphatic Diseases
Neoplasms
Immunoproliferative Disorders
Neoplasms by Histologic Type
Immune System Diseases

Lymphoproliferative Disorders
Lymphoma, Non-Hodgkin
Lymphoma
Hodgkin Disease

ClinicalTrials.gov processed this record on May 07, 2009